DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 3.46% to $9.22 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.50% to 19,954.30 and Dow Jones Industrial Average falling 0.32% to 44,424.25.
The stock's fall snapped a three-day winning streak.
Novavax Inc. closed 61.36% below its 52-week high of $23.86, which the company reached on June 6th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.12% to $146.82, Pfizer Inc. $(PFE)$ rose 0.31% to $26.09, and Merck & Co. Inc. $(MRK)$ fell 1.12% to $95.55.
Trading volume (4.4 M) remained 339,120 below its 50-day average volume of 4.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 24, 2025 17:30 ET (22:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。